Terrance P. Coyne - 02 Nov 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
EVP & CFO
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Terrance P. Coyne
Issuer symbol
RPRX
Transactions as of
02 Nov 2022
Net transactions value
-$236,846
Form type
4
Filing time
04 Nov 2022, 19:16:28 UTC
Previous filing
03 Aug 2022
Next filing
10 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Sale $236,846 -5,500 -0.57% $43.06 964,500 02 Nov 2022 By TPC RP 2021, LLC F1
holding RPRX Class A Ordinary Shares 1,500 02 Nov 2022 Direct
holding RPRX Class A Ordinary Shares 1,450 02 Nov 2022 By Spouse
holding RPRX Class A Ordinary Shares 23,270 02 Nov 2022 By IRA
holding RPRX Class A Ordinary Shares 24,170 02 Nov 2022 By Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.17 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

All reported transactions were effected pursuant to a 10b5-1 plan adopted by the reporting person.